semaglutide after gastric sleeve Surgery Bests Lifestyle Changes, GLP-1 for Durable Weight loss Adding Ozempic to endoscopic sleeve

The recent FDA approval of an oral version of semaglutide specifically for weight loss (distinct from Rybelsus , which is used for diabetes) represents a major leap in patient convenience

Physicians report major concerns about patient education, unrealistic expectations, rising healthcare costs, supply issues for diabetes patients, and widening health inequities

While research into GLP-1 medications and breast cancer is in its early stages, there are indications that these drugs could be an important tool in reducing the risk of breast cancer recurrence in overweight and obese patients and thrivers

It alleviates nonalcoholic fatty liver disease by improving mitochondrial metabolism and promoting cell survival [5]